Literature DB >> 27249221

Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome.

Pedro J Flores-Blanco1, Ángel López-Cuenca2, James L Januzzi3, Francisco Marín4,5, Marianela Sánchez-Martínez4, Miriam Quintana-Giner4, Ana I Romero-Aniorte4, Mariano Valdés4,5, Sergio Manzano-Fernández4,5.   

Abstract

BACKGROUND: Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations estimate glomerular filtration rate (GFR) more accurately than the Modification of Diet in Renal Disease (MDRD) equation. HYPOTHESIS: New CKD-EPI equations improve risk stratification in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and provide complementary information to the Global Registry of Acute Coronary Events (GRACE) risk score.
METHODS: We studied 350 subjects (mean age, 68 ± 12 years; 70% male) with NSTE-ACS. Estimated GFR was calculated using the MDRD and new CKD-EPI equations based on serum creatinine (SCr) and/or cystatin C (CysC) concentrations obtained within 48 hours of hospital admission. The primary endpoint was all-cause death during follow-up.
RESULTS: Over the study period (median, 648 days [interquartile range, 236-1042 days]), 31 patients died (0.05% events per person-year). Decedents had poorer renal-function parameters (P < 0.001). Both CysC-based CKD-EPI equations had the highest areas under the receiver operating characteristic curve for the prediction of all-cause mortality. After multivariate adjustment, only CysC-based CKD-EPI equations were independent predictors of all-cause mortality (CKD-EPISCr - CysC , per mL/min/1.73 m(2) : hazard ratio: 0.975, 95% confidence interval: 0.956-0.994, P = 0.009; CKD-EPICysC , per mL/min/1.73 m(2) : hazard ratio: 0.976, 95% confidence interval: 0.959-0.993, P = 0.005). Reclassification analyses showed that only CysC-based CKD-EPI equations improved predictive accuracy of the GRACE risk score.
CONCLUSIONS: In patients with NSTE-ACS, CysC-based CKD-EPI equations improved clinical risk stratification for mortality and added complementary prognostic information to the GRACE risk score.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27249221      PMCID: PMC6490737          DOI: 10.1002/clc.22556

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  40 in total

1.  Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.

Authors:  Jacobien C Verhave; Ron T Gansevoort; Hans L Hillege; Dick De Zeeuw; Gary C Curhan; Paul E De Jong
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

2.  Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials.

Authors:  C Michael Gibson; Raphaelle L Dumaine; Eli V Gelfand; Sabina A Murphy; David A Morrow; Stephen D Wiviott; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Journal:  Eur Heart J       Date:  2004-11       Impact factor: 29.983

3.  Impact of thyroid dysfunction on serum cystatin C.

Authors:  Manuel Fricker; Peter Wiesli; Michael Brändle; Beat Schwegler; Christoph Schmid
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

Review 4.  Cystatin C as a marker of GFR--history, indications, and future research.

Authors:  Guido Filler; Arend Bökenkamp; W Hofmann; Thierry Le Bricon; Cecília Martínez-Brú; Anders Grubb
Journal:  Clin Biochem       Date:  2005-01       Impact factor: 3.281

5.  Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.

Authors:  Wolfgang Koenig; Dorothee Twardella; Hermann Brenner; Dietrich Rothenbacher
Journal:  Clin Chem       Date:  2004-11-24       Impact factor: 8.327

Review 6.  Cystatin C.

Authors:  David J Newman
Journal:  Ann Clin Biochem       Date:  2002-03       Impact factor: 2.057

7.  Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome.

Authors:  Tomas Jernberg; Bertil Lindahl; Stefan James; Anders Larsson; Lars-Olof Hansson; Lars Wallentin
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

8.  A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.

Authors:  Kim A Eagle; Michael J Lim; Omar H Dabbous; Karen S Pieper; Robert J Goldberg; Frans Van de Werf; Shaun G Goodman; Christopher B Granger; P Gabriel Steg; Joel M Gore; Andrzej Budaj; Alvaro Avezum; Marcus D Flather; Keith A A Fox
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

9.  Increased cystatin C serum concentrations in patients with hepatic diseases of various severities.

Authors:  Shu-Chen Chu; Chi-Ping Wang; Yih-Hsin Chang; Yih-Shou Hsieh; Shun-Fa Yang; Jen-Ming Su; Chi-Chieh Yang; Hui-Ling Chiou
Journal:  Clin Chim Acta       Date:  2004-03       Impact factor: 3.786

10.  Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes.

Authors:  Jassim Al Suwaidi; Donal N Reddan; Kathryn Williams; Karen S Pieper; Robert A Harrington; Robert M Califf; Christopher B Granger; E Magnus Ohman; David R Holmes
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

View more
  4 in total

1.  Chronic kidney disease and coronary artery calcification in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).

Authors:  Cheng Suh-Chiou; Rosa M Moysés; Marcio S Bittencourt; Isabela M Bensenor; Paulo A Lotufo
Journal:  Clin Cardiol       Date:  2017-12-15       Impact factor: 2.882

2.  One-year mortality of patients with ST-Elevation myocardial infarction: Prognostic impact of creatinine-based equations to estimate glomerular filtration rate.

Authors:  Yoann Bataille; Olivier Costerousse; Olivier F Bertrand; Olivier Moranne; Hans Pottel; Pierre Delanaye
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

3.  Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft-Gault, Modification of Diet in Renal Disease-4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome.

Authors:  José Miguel Rivera-Caravaca; Juan Miguel Ruiz-Nodar; Antonio Tello-Montoliu; María Asunción Esteve-Pastor; Miriam Quintana-Giner; Andrea Véliz-Martínez; Esteban Orenes-Piñero; Ana Isabel Romero-Aniorte; Nuria Vicente-Ibarra; Vicente Pernias-Escrig; Luna Carrillo-Alemán; Elena Candela-Sánchez; Ignacio Hortelano; Beatriz Villamía; Miriam Sandín-Rollán; Laura Nuñez-Martínez; Mariano Valdés; Francisco Marín
Journal:  J Am Heart Assoc       Date:  2018-04-21       Impact factor: 5.501

4.  Prognostic of different glomerular filtration rate formulas in patients receiving percutaneous coronary intervention: insights from a multicenter observational cohort.

Authors:  Wei Chen; Pengyuan Chen; Zhonghan Ni; Yuanhui Liu; Wei Guo; Lei Jiang; Xuebiao Wei; Jiyan Chen; Ning Tan; Pengcheng He; Yansong Guo
Journal:  BMC Cardiovasc Disord       Date:  2020-07-18       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.